Table 2.
Pattern of use of prescription (Rx) and over the counter (OTC) NSAIDuse as reported by medication inventory among the 5655 participants who were present for all follow-up visits. Data from the Multi-Ethnic Study of Atherosclerosis.
| Exam | Aspirin (OTC) | Aspirin (Rx) |
|---|---|---|
| Baseline Exam | 23.9% | 5.3% |
| First Follow-up | 24.0% | 9.2% |
| Second Follow-up | 29.8% | 5.9% |
| Third Follow-up | 30.8% | 7.2% |
| Exam | Ibuprofen (OTC) | Ibuprofen (Rx) |
|---|---|---|
| Baseline Exam | 9.4% | 2.2% |
| First Follow-up | 6.6% | 1.8% |
| Second Follow-up | 6.2% | 1.6% |
| Third Follow-up | 6.1% | 1.8% |
| Exam | Naproxen (OTC) | Naproxen (Rx) |
|---|---|---|
| Baseline Exam | 1.6% | 3.1% |
| First Follow-up | 1.1% | 2.2% |
| Second Follow-up | 1.1% | 2.6% |
| Third Follow-up | 1.4% | 2.7% |